Showing posts with label Colon Cancer Treatment. Show all posts
Showing posts with label Colon Cancer Treatment. Show all posts

Monday, May 13, 2013

ICD 9 Code For Colorectal Cancer


Human gastrointestinal sector includes a vast thesis and is divided into various subdivisions in medical science. The gastroenterologist requires a huge study to master this subject. To cope with the increasing illnesses, diseases, situations, condition and symptoms of the human system, the experts have come out with ICD 9 specifications as a note for various injuries, symptoms and other conditions regarding intestinal system. In the same way, to cope with colon cancer, there are also available icd codes. ICD, the full form appears for International Classification of Diseases. From the name itself, we are able to know about the requirement of this type of coding. The first specifications for illnesses were not as like as those prevalent this day. In course of time with necessary improvisations, ICD 9 specifications have been brought out.

Colon cancer is a sickness where the colon is found to grow uncommonly without taking care of the body’s immune system or order. When this intestinal system goes to such a stage, where the cells turn melanoma then this situation is known as melanoma of the intestinal system. Cancer of the digestive tract is a widespread sickness and when the melanoma gets spread to different parts, and then it is called metastatic melanoma of the intestinal system. The development for this sickness is referred to metastatic colon cancer icd 9 concept. The research, diagnosis and the treatment for this sickness are all included in the ICD 9 index and also an improvised version of it is known as ICD-9-CM which is just a medical modification.

Other ICD 9 Codes for Various Cancers

ICD 9 concept for melanoma of the intestinal system ICD code is now approved worldwide in every healthcare sector and in medical center. Cancer is not out of the ordinary in this matter. There is discussion of lung cancer in lung icd 9 code-CM 197.0 where it speaks about metastatic melanoma which has come to the lung from other part of the human system. It is momentarily described as additional malig neo lung. This concept in general is for the purpose to look into a research and to confirm any irregularity if any.

Similar developments are also for prostate melanoma. Prostate melanoma icd 9 concept CM is endowed in code 185 and its various other forms are in 602.3, 233.4 198.1, 198.5, 196.6, 196.2 and 198.82. Coming to liver cancer, liver body organ melanoma icd 9 concept include are mentioned in various part of 155 areas. The research for melanoma of the intestinal system has been listed to colonoscopy icd 9 code and it has also helped much in the colon cancer treatment. Cancer can also reach up to the ovary and for this type of situation; one should talk about ovarian melanoma icd 9 code 198.6.


Colopril

Monday, April 15, 2013

Stivarga: New Treatment Options for Colorectal Cancer Patients

"New therapies offer hope for patients living with advanced sickness and highlight the oncology community's ongoing commitment to patients offering not only to be able to improve their quality of life, but in some circumstances even enhances their way of life," says Barry D. Stein, Us president of the Colorectal Cancer Association of Canada. "Stivarga represents another new option for Canadian patients and it is important that this amazing treatment be made available to all Canadians living with metastatic abdominal program melanoma to ensure they have every reasonable probability to fight this sickness." "I want to make the most out of every moment," says Stephen Dunn, level IV colon cancer patient."Treatment options that give patients more time are one more step on an important journey - celebrating another day with my family means everything to me, and also to them."

The data also revealed a survival benefit in the regorafenib arm across nearly all subgroups analyzed.  The most serious adverse reactions are hepatotoxicity, hemorrhage and gastrointestinal perforation.  The most common treatment related adverse reactions are fatigue, hand-foot-skin reaction (HFSR), diarrhea and anorexia. "A metastatic abdominal  melanoma analysis can be frustrating for the patient as well as for themselves associates and close relatives," says Bunnie Schwartz, Co-founder and Us president of Colon Cancer Canada. "New and available treatment options that can prolong a patient's life are critical - the additional time allows the patient to continue to build memories that will be cherished by their families."


"Stivarga's approval in Canada and the united states further decides Bayer as a company dedicated to helping the way of life of patients," Christian Lauterbach, President & CEO of Bayer Inc. in Canada. " Stivarga is an important stage for Bayer in enhancing our oncology profile and offering doctors and patients with new and effective tools to fight melanoma and increase way of life."

About Colon Cancer
Colorectal Cancer (CRC) is the third most common melanoma worldwide, with over 1.2 million circumstances happening every season. It is the second major cause of melanoma deaths in Canada.  An estimated 23,300 Canadians were clinically identified as having abdominal program melanoma this season and 9,200 passed away of it.

Metastatic cancer is melanoma that has distribute from the place where it first started to another place in the program. A growth established by metastatic melanoma cells is known as a metastatic tumour or a metastasis. The process by which melanoma cells distribute to other parts of body is also known as metastasis. Of the patients with abdominal program melanoma, approximately 20,600 have metastatic abdominal program melanoma. mCRC is one of the most competitive types of cancer; however, ongoing analysis and new therapies have prolonged average overall achievements to more than 20 months, an increase that has customized the view of amazing abdominal program melanoma from an acute to a chronic.

About Stivarga
Regorafenib is an oral multi-kinase chemical affecting systems fortumour growth and progression - angiogenesis, oncogenesis and the tumour microenvironment. In preclinical studies, regorafenib stops several angiogenic VEGF receptor tyrosine kinases that be a factor in growth angiogenesis and lymphangiogenesis (the growth of new veins and the the lymphatic program vessels). It also stops various oncogenic and growth microenvironment kinases such as VEGFR 1-3, KIT, RET, PDGFR, and FGFR, which individually and mutually effect upon tumour growth, formation of a stromal microenvironment and disease progression.


Safety and adverse activities were similar to those observed with other tyrosine kinase inhibitors (TKIS) The most frequently observed adverse drugs reactions in patients getting regorafenib were asthenia/fatigue, reduced hunger and diet, appetite and food intake, hand-foot-skin reaction, diarrhea, mucositis, weight loss, infection, hypertension and dysphonia. The most serious adverse drug reactions in patients receiving regorafenib were hepatotoxicity, hemorrhage and gastrointestinal perforation.Regorafenib is also under investigation in metastatic and/or unresectable gastrointestinal stromal tumours (GIST) for patients whose disease has progressed despite prior treatment with imatinib and sunitinib. 

Source: http://bit.ly/9PDs0S

Colopril

Monday, April 8, 2013

Best Treatment Options for Colon Cancer

Cancer of the colon is highly treatable when handled at early stage. The type of treatment your doctor suggests will rely mostly on the level of your melanoma. The Virginia G. Piper Cancer Center offers a full variety of therapies to fit your individual needs, including:

Chemotherapy

Chemo uses drugs to remove melanoma cells. Chemo can be used to remove melanoma cells after surgery treatment, to control tumor growth or to decrease symptoms of digestive tract melanoma. Your doctor may recommend chemo treatment if your melanoma has distribute beyond the wall of colon or if your melanoma has distribute to the lymph nodes.

Clinical Trials

Nowadays, patients clinically diagnosed as melanoma not only have availability the latest therapies and innovative technology; they have the opportunity to participate in clinical trials that study the effects of certain treatments for their particular cancer.

Virginia G. Piper Cancer Center Clinical Trials, a cooperation between  Scottsdale Healthcare Research Institute and the Translational Genomics Research Institute (TGen), is one of the country's leading features for new drug development. We offer more Level I healthcare research than any other melanoma center in Arizona, allowing patients access to new therapies for the first time in the world.

daVinci Robotic Surgery

In 2003, Scottsdale Healthcare was the first hospital in Arizona to purchase the daVinci robot-assisted surgical system. This system is used for a less-invasive approach to functions, which allows for smaller incisions, less scarring damage and faster restoration. For digestive tract surgery treatment patients, this typically means three or four incisions that are each less than one-third of an inches long. Another 1- to 1.5-inch cut is made to remove the unhealthy digestive tract tissue. Compared to 5-inch cut usually needed during traditional open digestive tract surgery treatment, it’s clear to understand why da Vinci surgery is called non-invasive.
It also has other advantages for patients. Robotic colorectal surgery treatment patients usually are put in the hospital only two or three days, in comparison to five or six for open-surgery patients. The assistance of the automated system allows for much more accurate healthcare activities, so  the surgeon can remove melanoma with less injury to the nearby anxiety and blood veins.

 Dr. Andrew Kassir performed the first automatic digestive tract surgery treatment in Arizona during 2009 at Scottsdale Healthcare and now, doctors from across the country travel to watch and learn during his robotic techniques. Robotic surgery treatment for the colon is a recent development.

Radiation Therapy

Radiotherapy uses rays to eliminate any melanoma cells that might remain after surgery treatment, to shrink large cancers before an operation so that they can be removed more easily, or to decrease symptoms of digestive tract melanoma and rectal melanoma. Radiotherapy is hardly ever used in early-stage digestive tract melanoma, but is a routine part of dealing with rectal melanoma, especially if melanoma has occupied through the surfaces of the rectum or to close by lymph nodes. Radiotherapy, usually along with rays treatment, may be used after surgery treatment to decrease the risk that melanoma may happen again in the area of the rectum where it began.

Transanal Endoscopic Microsurgery (TEM)

The  Virginia G. Piper Cancer Center  is extremely pleased to be one of less than 100 centers in the United States to offer transanal endoscopic microsurgery (TEM), a non-invasive healthcare technique that allows the removal of a melanoma mass or polyp in the rectum that might otherwise require a major stomach surgery treatment.

Sunday, March 24, 2013

Colorectal Cancer: Prevention, Diagnosis & Treatment

March is Colon Cancer Awarness Month. A few weeks ago, we provided you introduction to Colon Cancer, such as research, information on the threats and symptoms of abdominal tract melanoma, and information on the most generally recommended analytic evaluate, the colonoscopy. This week, we’re following up with information on avoiding and dealing with cancer of the colon or rectum (also known as colorectal cancer), and offering more information on other techniques for discovering.

Colorectal Cancer Prevention
Receiving regular assessments is going to be the best way to avoid colorectal cancer. Catching melanoma early while it is still curable and/or removing polyps before they turn cancerous are key elements to success. According to the America Cancer Community, “people who have not determined threats (other than age) should begin regular testing at age 50. If you have a powerful ancestry of colon polyps or melanoma, getting tested prior to age 50 is strongly recommended. Other advice you will see for cancer avoidance is similar across cancers. A few things you can do to improve your system and battle off melanoma, such as abdominal tract melanoma, include: giving up smoking cigarettes, exercising regularly, eating a  healthy and balanced, well-balanced diet, and keeping a appropriate  healthy and balanced weight.

Diagnosing Colon Cancer
While a colonoscopy is the most common technique of discovering and setting up abdominal tract cancer and/or other abdominal conditions, there are several other techniques used including:
  • Flexible Sigmoidoscopy: This evaluate uses a flexible, lighted pipe with a small photographic camera on the end. It can travel the complete of the rectum and half of the abdominal system.
  • Colonoscopy: This evaluate allows the doctor to look at the entire length of the abdominal system and rectum with a colonoscope, which is a longer version of a sigmoidoscope.
  • Double Contrast Barium Enema: A type of x-ray evaluate using barium sulfate, which is a chalky liquid, and air to review the inner part of the abdominal system and rectum, presenting infrequent areas on x-rays.
  • CT Colonography (Virtual Colonoscopy): This is a advanced level type of measured tomography (CT or CAT) check out of the abdominal system and rectum. It is non-invasive, can be done easily, and does not require sleep.
Treating Colon Cancer
After cancer is medically diagnosed and held, your multidisciplinary colorectal cancer care team will create a treatment plan using one, or a combination, of these main therapy methods:

  • Surgery – Surgery treatment therapy is the main remedies for abdominal tract melanoma. This process includes removing cancer, a area of normal cells on either side of melanoma, and any local lymph nodes.
  • Rays Therapy – A type of melanoma therapy that uses ionizing radiation energy to eliminate cancer cells and decrease melanoma malignancies. Colon melanoma may be managed using exterior ray radiation before surgery to contract the growth or after surgery to eliminate any staying melanoma cells.
  • Chemotherapy – Chemo is drugs delivered to the system to remove melanoma cells or decrease their effect. It goals cells that split easily, a feature of most melanoma cells. Chemo is often used to support and enhance other melanoma treatments.